Regis Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Regis heeft een totaal eigen vermogen van $56.8M en een totale schuld van $99.5M, wat de schuld-eigenvermogensverhouding op 175.3% brengt. De totale activa en totale passiva bedragen respectievelijk $530.5M en $473.7M. De EBIT Regis is $21.7M waardoor de rentedekking 0.9 is. Het heeft contanten en kortetermijnbeleggingen van $10.1M.

Belangrijke informatie

175.3%

Verhouding schuld/eigen vermogen

US$99.55m

Schuld

Rente dekkingsratio	0.9x
Contant	US$10.07m
Aandelen	US$56.79m
Totaal verplichtingen	US$473.71m
Totaal activa	US$530.50m

Recente financiële gezondheidsupdates

Health Check: How Prudently Does Regis (NYSE:RGS) Use Debt?

Mar 31

Is Regis (NYSE:RGS) Weighed On By Its Debt Load?

Dec 28

Recent updates

Regis Corporation (NYSE:RGS) Analysts Just Trimmed Their Revenue Forecasts By 12%

May 15

Regis EPS misses by $0.69, misses on revenue

May 05

Health Check: How Prudently Does Regis (NYSE:RGS) Use Debt?

Mar 31

Is There An Opportunity With Regis Corporation's (NYSE:RGS) 49% Undervaluation?

Mar 03

Regis Corporation (NYSE:RGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.00

Feb 05

Regis EPS misses by $0.56, misses on revenue

Feb 04

Reflecting on Regis' (NYSE:RGS) Share Price Returns Over The Last Year

Jan 26

Is Regis (NYSE:RGS) Weighed On By Its Debt Load?

Dec 28

If We Are Past The Pandemic, Supercuts Owner Regis Looks Interesting

Dec 03

Should You Review Recent Insider Transactions At Regis Corporation (NYSE:RGS)?

Dec 02

Regis EPS misses by $0.65, misses on revenue

Nov 02

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $42.1M ) van RGS } dekken niet de korte termijn passiva ( $103.5M ).

Langlopende schulden: De kortetermijnactiva van RGS ( $42.1M ) dekken de langetermijnschulden ( $370.2M ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 157.6% ) RGS wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van RGS is de afgelopen 5 jaar gestegen van 27.8% naar 175.3%.

Schuldendekking: De operationele kasstroom van RGS is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: De rentebetalingen van RGS op haar schulden worden niet goed gedekt door EBIT ( 0.9 x dekking).

Regis Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

Recente financiële gezondheidsupdates

NYSE Regulation Determines to Commence Proceedings to Delist Regis' Common Stock from the NYSE

NYSE to Commence Delisting Proceedings Against Regis Corporation

Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements

Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements

Health Check: How Prudently Does Regis (NYSE:RGS) Use Debt?

Is Regis (NYSE:RGS) Weighed On By Its Debt Load?

Recent updates

Regis Corporation to Report Q1, 2025 Results on Nov 06, 2024

Regis Corporation, Annual General Meeting, Nov 06, 2024

Regis: Focus On Turnaround Not Metrics

Regis Corporation Announces Executive Changes

Regis Corporation to Report Q4, 2024 Results on Aug 28, 2024

Regis: A Compelling Turnaround

Gary Wyetzner Provides Information to Shareholders

Regis Refinancing A Home Run For Shareholders

Regis Corporation to Report Q3, 2024 Results on May 01, 2024

Regis Corporation: Still Attempting A Turnaround

Regis Corporation Reports Impairment for the Second Quarter Ended December 31, 2023

Regis Corporation to Report Q2, 2024 Results on Jan 31, 2024

William Charters Issues Letter to Regis Corporation

Galloway Capital Partners, LLC Issues a Letter to Regis Corporation

NYSE Regulation Determines to Commence Proceedings to Delist Regis' Common Stock from the NYSE

NYSE to Commence Delisting Proceedings Against Regis Corporation

Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements

Regis Corporation Announces Reverse Stock Split to Regain Compliance with Minimum Bid Price Requirements

New major risk - Financial data availability

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Share price stability

Consensus EPS estimates upgraded to US$0.13 loss, revenue downgraded

Regis Corporation to Report Q1, 2024 Results on Nov 01, 2023

Consensus EPS estimates fall by 82%

Regis Corporation, Annual General Meeting, Oct 24, 2023

Regis Corporation Reports Impairment Charges for the Fourth Quarter Ended June 30, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Regis Corporation to Report Q4, 2023 Results on Aug 23, 2023

Regis Corporation Appoints Ms. Nancy Benaccito the Board of Directors of the Company, Effective May 1, 2023

Regis Corporation Reports Impairment Charges for the Third Quarter Ended March 31, 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Second quarter 2023 earnings released: US$0.055 loss per share (vs US$0.11 loss in 2Q 2022)

Regis GAAP EPS of -$0.05, revenue of $60M

Regis Corporation to Report Q2, 2023 Results on Feb 01, 2023

First quarter 2023 earnings released: US$0.04 loss per share (vs US$0.25 loss in 1Q 2022)

Regis Non-GAAP EPS of -$0.02, revenue of $61.9M

Regis Corporation to Report Q1, 2023 Results on Nov 01, 2022

Regis Corporation, Annual General Meeting, Oct 25, 2022

Regis Corporation appoints Michelle DeVore as Senior Vice President, Head of Marketing

Regis Non-GAAP EPS of -$0.07, revenue of $66.1M

Regis Corporation to Report Q4, 2022 Results on Aug 23, 2022

Regis successfully amends credit facility maturity date and term loan amount

SOHAM INC completed the acquisition of Opensalon Pro from Regis Corporation (NYSE : RGS).

Regis Corporation(NYSE:RGS) dropped from Russell Microcap Value Index

SOHAM INC agreed to acquire Opensalon Pro from Regis Corporation (NYSE : RGS) for $39 million.

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Regis Corporation Appoints Matthew Doctor as Chief Executive Officer

Forecast to breakeven in 2023

Regis Corporation Announces Management Appointments

Regis Corporation Announces Impairment Charges for the Second Quarter Ended December 31, 2021

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Chief Development Officer, Executive VP, General Counsel & Secretary Amanda Rusin has left the company

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.98 loss in 1Q 2021)

High number of new directors

Price target decreased to US$5.75

Full year 2021 earnings released: US$3.15 loss per share (vs US$4.79 loss in FY 2020)

Price target decreased to US$9.25

Regis Corporation (NYSE:RGS) Analysts Just Trimmed Their Revenue Forecasts By 12%

Third quarter 2021 earnings released: US$0.30 loss per share (vs US$2.10 loss in 3Q 2020)

Regis EPS misses by $0.69, misses on revenue

Health Check: How Prudently Does Regis (NYSE:RGS) Use Debt?

Is There An Opportunity With Regis Corporation's (NYSE:RGS) 49% Undervaluation?

New 90-day high: US$12.64

Regis Corporation (NYSE:RGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$11.00

Second quarter 2021 earnings released: US$0.92 loss per share (vs US$0.27 loss in 2Q 2020)

Earnings beat expectations, revenue disappoints

Regis EPS misses by $0.56, misses on revenue

Regis Corporation to Report Q2, 2021 Results on Feb 04, 2021

New 90-day high: US$11.80